BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26028048)

  • 21. CD6 is a target for cancer immunotherapy.
    Ruth JH; Gurrea-Rubio M; Athukorala KS; Rasmussen SM; Weber DP; Randon PM; Gedert RJ; Lind ME; Amin MA; Campbell PL; Tsou PS; Mao-Draayer Y; Wu Q; Lanigan TM; Keshamouni VG; Singer NG; Lin F; Fox DA
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33497367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of CD4 T cell function via CD6-targeting.
    Freitas RF; Basto A; Almeida SCP; Santos RF; Gonçalves CM; Corria-Osorio J; Carvalho T; Carmo AM; Oliveira VG; Leon K; Graca L
    EBioMedicine; 2019 Sep; 47():427-435. PubMed ID: 31481324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dual role of CD6 as a therapeutic target in cancer and autoimmune disease.
    Gurrea-Rubio M; Fox DA
    Front Med (Lausanne); 2022; 9():1026521. PubMed ID: 36275816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CD6 interactome orchestrates ligand-independent T cell inhibitory signaling.
    Santos RF; de Sousa Linhares A; Steinberger P; Davis SJ; Oliveira L; Carmo AM
    Cell Commun Signal; 2024 May; 22(1):286. PubMed ID: 38790044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study.
    Yuan D; Yang J; Wu W; Amier Y; Li X; Wan W; Huang Y; Li J; Yu X
    Int Urol Nephrol; 2024 May; ():. PubMed ID: 38776057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous and viral microRNAs in nasal secretions of water buffaloes (Bubalus bubalis) after Bubaline alphaherpesvirus 1 (BuHV-1) challenge infection.
    Lecchi C; Ceciliani F; Petrini S; Cappelli G; Grassi C; Balestrieri A; Galiero G; DeCarlo E; Salvi G; Panzeri F; Gini C; Cafiso A; Agazzi A; Martucciello A
    Vet Res; 2023 Jun; 54(1):44. PubMed ID: 37277883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD6-mediated inhibition of T cell activation via modulation of Ras.
    Henriques SN; Oliveira L; Santos RF; Carmo AM
    Cell Commun Signal; 2022 Nov; 20(1):184. PubMed ID: 36414966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratinocyte-induced costimulation of human T cells through CD6 - but not CD2 - activates mTOR and prevents oxidative stress.
    Orlik C; Berschneider KM; Jahraus B; Niesler B; Balta E; Schäkel K; Schröder-Braunstein J; Souto-Carneiro MM; Samstag Y
    Front Immunol; 2022; 13():1016112. PubMed ID: 36353616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis.
    Shen Q; He Y; Qian J; Wang X
    Front Mol Biosci; 2022; 9():960457. PubMed ID: 36339710
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinetic proofreading through the multi-step activation of the ZAP70 kinase underlies early T cell ligand discrimination.
    Voisinne G; Locard-Paulet M; Froment C; Maturin E; Menoita MG; Girard L; Mellado V; Burlet-Schiltz O; Malissen B; Gonzalez de Peredo A; Roncagalli R
    Nat Immunol; 2022 Sep; 23(9):1355-1364. PubMed ID: 36045187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies.
    Sui S; Li Z; Tan J; Wang L; Luo G; Zeng C; Luo OJ; Chen C; Li Y
    J Oncol; 2022; 2022():2787426. PubMed ID: 35983088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood transcriptome analysis revealing aging gene expression profiles in red panda.
    Luo J; Zhang L; Shen F; Luo L; Chen L; Fan Z; Hou R; Yue B; Zhang X
    PeerJ; 2022; 10():e13743. PubMed ID: 35898935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer.
    Liu B; Zhai J; Wang W; Liu T; Liu C; Zhu X; Wang Q; Tian W; Zhang F
    Front Mol Biosci; 2022; 9():872932. PubMed ID: 35517856
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of potential blood biomarkers associated with suicide in major depressive disorder.
    Mamdani F; Weber MD; Bunney B; Burke K; Cartagena P; Walsh D; Lee FS; Barchas J; Schatzberg AF; Myers RM; Watson SJ; Akil H; Vawter MP; Bunney WE; Sequeira A
    Transl Psychiatry; 2022 Apr; 12(1):159. PubMed ID: 35422091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome.
    Casadó-Llombart S; Gheitasi H; Ariño S; Consuegra-Fernández M; Armiger-Borràs N; Kostov B; Ramos-Casals M; Brito-Zerón P; Lozano F
    Front Med (Lausanne); 2022; 9():822290. PubMed ID: 35372412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.
    Chalmers SA; Ayilam Ramachandran R; Garcia SJ; Der E; Herlitz L; Ampudia J; Chu D; Jordan N; Zhang T; Parodis I; Gunnarsson I; Ding H; Shen N; Petri M; Mok CC; Saxena R; Polu KR; Connelly S; Ng CT; Mohan C; Putterman C
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DES-Tcell is a knowledgebase for exploring immunology-related literature.
    AlSaieedi A; Salhi A; Tifratene F; Raies AB; Hungler A; Uludag M; Van Neste C; Bajic VB; Gojobori T; Essack M
    Sci Rep; 2021 Jul; 11(1):14344. PubMed ID: 34253812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors
    Casadó-Llombart S; Velasco-de Andrés M; Català C; Leyton-Pereira A; Lozano F; Bosch E
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative Splicing of Pre-mRNA in the Control of Immune Activity.
    Su Z; Huang D
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
    Caballero A; Filgueira LM; Betancourt J; Sánchez N; Hidalgo C; Ramírez A; Martinez A; Despaigne RE; Escalona A; Diaz H; Meriño E; Ortega LM; Castillo U; Ramos M; Saavedra D; García Y; Lorenzo G; Cepeda M; Arencibia M; Cabrera L; Domecq M; Estévez D; Valenzuela C; Lorenzo P; Sánchez L; Mazorra Z; León K; Crombet T
    Clin Transl Immunology; 2020; 9(11):e1218. PubMed ID: 33304584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.